[Long-term use of the calcium antagonist nifedipine (corinfar) in the treatment of patients with primary pulmonary hypertension]. 1988

A Khosseĭn, and N M Mukharliamov, and V Iu Mareev, and N M Lobova, and F T Ageev

Sixteen patients on long-term treatment for primary pulmonary hypertension were studied. The results were compared after a single 20 mg dose, a two-week course and long-term (13.9 months on the average) use of the drug (40 mg/day). Pulmonary arterial catheterization, thermodilution and occlusion plethysmography were used. Changes in central and peripheral hemodynamic parameters were unidirectional and similar at all stages of the study. Nifedipine improved hemodynamics, as evidenced by selected criteria, in 80% of patients exposed to acute tests, in 91% after a course of treatment and in 58% after long-term use. Therefore, considering the ability of nifedipine to improve pulmonary hemodynamics as well as stable effect over more than one year of treatment, and the absence of marked side effects, this drug can be regarded as the most effective vasodilating agent for the treatment of primary pulmonary hypertension.

UI MeSH Term Description Entries
D006976 Hypertension, Pulmonary Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES. Pulmonary Hypertension
D008297 Male Males
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A Khosseĭn, and N M Mukharliamov, and V Iu Mareev, and N M Lobova, and F T Ageev
November 1987, Kinderarztliche Praxis,
A Khosseĭn, and N M Mukharliamov, and V Iu Mareev, and N M Lobova, and F T Ageev
January 1983, Zeitschrift fur arztliche Fortbildung,
A Khosseĭn, and N M Mukharliamov, and V Iu Mareev, and N M Lobova, and F T Ageev
January 1988, Biulleten' Vsesoiuznogo kardiologicheskogo nauchnogo tsentra AMN SSSR,
A Khosseĭn, and N M Mukharliamov, and V Iu Mareev, and N M Lobova, and F T Ageev
January 1989, Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna,
A Khosseĭn, and N M Mukharliamov, and V Iu Mareev, and N M Lobova, and F T Ageev
August 1984, American heart journal,
A Khosseĭn, and N M Mukharliamov, and V Iu Mareev, and N M Lobova, and F T Ageev
April 1984, British journal of obstetrics and gynaecology,
A Khosseĭn, and N M Mukharliamov, and V Iu Mareev, and N M Lobova, and F T Ageev
June 1983, American heart journal,
A Khosseĭn, and N M Mukharliamov, and V Iu Mareev, and N M Lobova, and F T Ageev
May 1986, Arquivos brasileiros de cardiologia,
A Khosseĭn, and N M Mukharliamov, and V Iu Mareev, and N M Lobova, and F T Ageev
April 1983, American heart journal,
A Khosseĭn, and N M Mukharliamov, and V Iu Mareev, and N M Lobova, and F T Ageev
January 1990, Zeitschrift fur Erkrankungen der Atmungsorgane,
Copied contents to your clipboard!